CompletedPHASE1, PHASE2NCT02016235
Role Of Phosphorus And FGF 23 In Patients With Dent Disease
Studying Dent disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- John C Lieske, M.D., M.DMayo Clinic
- Intervention
- Phosphorus Supplement(drug)
- Enrollment
- 30 enrolled
- Eligibility
- MALE
- Timeline
- 2014 – 2019
Study locations (1)
- Mayo Clinic, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02016235 on ClinicalTrials.govOther trials for Dent disease
Additional recruiting or active studies for the same condition.